Keywords
How to Cite
Abstract
Treatment of tumors in kidney recipients is not an easy task, due to lifelong immunosuppression. The leading place among all graft tumors is skin cancer - 31%, and the 3rd place is occupied by tumors of the genitourinary system (0.35.8%). The main method of treating skin cancer is surgical, which is difficult to perform in some localities. An alternative method is radiation therapy. The tumor in the graft is rare. The method of treating a tumor of this localization is surgical, which can lead to nephrectomy of the graft. Radiofrequency-assisted graft resection is an original treatment method. Its use provides good immediate and long-term treatment results. Patient B., born in 1977, 20.10.2016 was diagnosed with a tumor in kidney graft T1aN0M0 (stage I). Allotransplantation of the kidney to the left iliac vessels from 15.01.2012. When choosing the method, there were difficulties: an obese patient, graft eventration in anamnesis, according to MSCT, intestinal loops are located around the kidney graft, and fibrous changes around the kidney graft. Laparoscopic radiofrequency - assisted renal graft resection was chosen as the method of treatment. Operation duration-120 minutes, blood loss-100 ml. The postoperative period was uneventful. Currently, there are no signs of relapse. In June 2019-the appearance of a skin formation in the area of the left auricle, histologically-squamous cell cancer, G III. From 12.07.2019-short-focus radiation therapy with ROD 3 G, SOD 54 G. The treatment was carried out satisfactorily. In October 2019-a similar formation on the skin of the left cheek. From 14.11.2019-short-focus radiation therapy, ROD 2.75 G, SOD 55 G. The treatment was carried out satisfactorily. Currently, there are no signs of a recurrence of the tumor. The use of modern techniques and equipment makes it possible to perform treatment of primary multiple tumors in patients after kidney transplants with satisfactory cosmetic, functional and oncological results.
References
Янковой А.Г, Прокопенко Е.И., Синютин А.А., Степанов В.А. и др. Опухолевое поражение трансплантированной почки // Клиническая нефрология. - 2016. - Т. 3. - С. 53-59.
Шевцов И.В. Обоснование роли радиочастотно-ассистированной резекции в хирургическом лечении локализованного рака почки : диссертация.. кандидата медицинских наук : 14.01.17 / Шевцов Иван Владимирович. - Санкт-Петербург, 2013. - 74 с.: ил.13.
Tillou X., Guleryuz K., Collon S., Doerfler A. Renal cell carcinoma in functional renal graft: Toward ablative treatments // Transplant. Rev. (Orlando). - 2016. - Vol. 30(1). - P 20-26. - doi: 10.1016/j.trre.2015.07.001.
AlBugami M., Kiberd B. Malignacies: pre and post transplantation strategies // Transplant Rev (orlando). - 2014. - Vol. 28(2). - P. 76-3. - doi: 10.1016/j. trre.2013.12.002.
Engels E.A., Pfeiffer R.M., Fraumeni J.F. Jr. et al. Spectrum of cancer risk among US solid organ transplant recipients // JAMA. - 2011. - Vol. 306(17). - P 1891901. - doi: 10.1001/jama.2011.1592.
Collet D., Mumford L., Banner N.R. et al. Comparison of the incidenceof malignancy in recipients of different types of organ: a UK registry audit // Am. J. Tranplant. - 2010. - Vol. 10. - P. 1889-96. - doi: 10.1111/j.1600-6143.2010.03181.x.
Viart L., Surga N., Collon S. et al. The High Rate of de novo Graft Carcinomas in Renal Transplant Recipients // Am J Nephrol. - 2013. - Vol. 37. - P 91-96. - doi: 10.1159/000346624.
Neuzillet Y, Tillou X., Mathieu R. et al. Comite de Transplantation de i'Association Francaise d'Urologie; Comite de i'Association Francaise d'Urologie. Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in general population // Eur. Urol. - 2011. - Vol. 60(2). - P. 366-73.
Tillou X., Doerfler A., Collon S. et al. Comite de Transplan tation de l Association Francaise d Urologie (CTAFU). De novo kidney graft tumors: results from a multicentric retrospective national study // Am J Transplant. - 2012. - Vol. 12(12). - P 3308 - 15.
Ploussard G., Chambade D., Meria P. et al. Biopsy - confirmed de novo renal cell carcinoma (RCC) in renal grafts: single - centre management management experients in a 2396 recipient cohort // BJU Int. - 2012. - Vol. 109(2). - P 195 - 9. - doi: 10.1111/j.1464-410X.2011.10315.x
Claudio Ponticelli, David Cucchiari, PierLuca Bencini. Skin Cancer in Kidney Transplant Recipients // J Neuphrol. - 2014. - Vol. 27(4). - P 385-94. - doi: 10.1007/ s40620-014-0098-4.
Veltri A., Grosso M., Castagneri F. et al. Radiofrequency thermal ablation of small in transplanted kidneys: an evolving nephron-sparing option // J. Vasc. Interv. Radiol. - 2009. - Vol. 20(5). - P. 674 - 9. - doi: 10.1016/j.jvir.2009.01.018.
Lugo-Baruqui J.A., Guerra G., Chen L. et al. Living donor renal transplantation with incidental renal cell carcinoma from donor allograft // Transpl. Int. - 2015. - Vol. 28(9). - P. 1126-1130. - doi: 10.1111/tri.12594.
Grossi Marconi D., da Costa Resende B., Rauber E. et al. Head and Neck Non-Melanoma Skin Cancer Treated by Superficial X-Ray Therapy: An Analysis of 1021 Cases // PLoS One. - 2016. - Vol. 11. - e0156544. - doi: 10.1371/journal.pone.0156544.
Schulte K.W., Lippold A., Auras C. et al. Soft x-ray therapy for cutaneous basal cell and squamous cell carcinomas // J Am Acad Dermatol. - 2005. - Vol. 53. - P 9931001. - doi: 10.1016/j.jaad.2005.07.045.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
© АННМО «Вопросы онкологии», Copyright (c) 2020